摘要
报道1例肺栓塞并可疑抗磷脂综合征患者的药学监护方案,临床药师通过查阅相关文献、指南,分析导致肺栓塞的因素,结合患者情况提出抗凝方案,可疑抗磷脂综合征时调整抗凝药物从利伐沙班换为华法林,为患者合理用药提供建议。
The pharmaceutical care of a patient with pulmonary embolism and suspected antiphospholipid was reported.Clinical pharmacists analyzed the possible factors of pulmonary embolism by reviewing literature and guidelines,and provided optimal anticoagulation regimen based on the patient's situation.For the rational drug use for the patient,the anticoagulant was converted from rivaroxaban to warfarin when antiphospholipid syndrome was suspected.
作者
张丽新
武雪梅
杨宏昕
唐筱婉
都丽萍
ZHANG Li-xin;WU Xue-mei;YANG Hong-xin;TANG Xiao-wan;DU Li-ping(Department of Pharmacy,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Pharmacy,Inner Mongolia Autonomous Region People's Hospital,Huhehaote 010017,China;Internal Medicine Department,the Third Hospital of Hohhot,Huhehaote 010050,China)
出处
《临床药物治疗杂志》
2022年第6期89-92,共4页
Clinical Medication Journal
基金
首都卫生发展科研专项项目(首发2018-3-4017)。
关键词
肺栓塞
抗磷脂综合征
复方口服避孕药
直接口服抗凝药
狼疮抗凝物
pulmonary embolism
antiphospholipid syndrome
combined oral contraceptives
direct oral anticoagulant
lupus anticoagulant
